Literature DB >> 7624319

Extrapituitary expression of the rat V1b vasopressin receptor gene.

S J Lolait1, A M O'Carroll, L C Mahan, C C Felder, D C Button, W S Young, E Mezey, M J Brownstein.   

Abstract

[Arg8]vasopressin (AVP) stimulates adrenocorticotropic hormone release from the anterior pituitary by acting on the V1b AVP receptor. This receptor can be distinguished from the vascular/hepatic V1a and renal V2 AVP receptors by its differential binding affinities for structural analogous of AVP. Recent studies have shown that the cloned V1a and V2 receptors are structurally related. We have isolated a clone encoding the V1b receptor from a rat pituitary cDNA library using polymerase chain reaction (PCR)-based methodology. The rat V1b receptor is a protein of 421 amino acids that has 37-50% identity with the V1a and V2 receptors. Homology is particularly high in the seven putative membrane-spanning domains of these guanine nucleotide-binding protein-coupled receptors. Expression of the recombinant receptor in mammalian cells shows the same binding specificity for AVP agonists and antagonists as the rat pituitary V1b receptor. AVP-stimulated phosphotidylinositol hydrolysis and intracellular Ca2+ mobilization in Chinese hamster ovary or COS-7 cells expressing the cloned receptor suggest second messenger signaling through phospholipase C. RNA blot analysis, reverse transcription PCR, and in situ hybridization studies reveal that V1b receptor mRNA is expressed in the majority of pituitary corticotropes as well as in multiple brain regions and a number of peripheral tissues, including kidney, thymus, heart, lung, spleen, uterus, and breast. Thus, the V1b receptor must mediate some of the diverse biological effects of AVP in the pituitary as well as other organs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7624319      PMCID: PMC41413          DOI: 10.1073/pnas.92.15.6783

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

Review 1.  Neurohypophyseal hormone receptor systems in brain and periphery.

Authors:  S Jard; C Barberis; S Audigier; E Tribollet
Journal:  Prog Brain Res       Date:  1987       Impact factor: 2.453

2.  Arginine vasopressin as a thyrotropin-releasing hormone.

Authors:  M D Lumpkin; W K Samson; S M McCann
Journal:  Science       Date:  1987-02-27       Impact factor: 47.728

3.  The cloned vasopressin V1a receptor stimulates phospholipase A2, phospholipase C, and phospholipase D through activation of receptor-operated calcium channels.

Authors:  E M Briley; S J Lolait; J Axelrod; C C Felder
Journal:  Neuropeptides       Date:  1994-07       Impact factor: 3.286

4.  Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1984-01-25       Impact factor: 16.971

5.  Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis.

Authors:  S Jard; R C Gaillard; G Guillon; J Marie; P Schoenenberg; A F Muller; M Manning; W H Sawyer
Journal:  Mol Pharmacol       Date:  1986-08       Impact factor: 4.436

6.  Hypothermia induced by centrally administered vasopressin in rats. A structure-activity study.

Authors:  G Meisenberg; W H Simmons
Journal:  Neuropharmacology       Date:  1984-10       Impact factor: 5.250

7.  Cellular localization of vasopressin V1a receptor messenger ribonucleic acid in adult male rat brain, pineal, and brain vasculature.

Authors:  N L Ostrowski; S J Lolait; W S Young
Journal:  Endocrinology       Date:  1994-10       Impact factor: 4.736

8.  Structure, characterization, and expression of the rat oxytocin receptor gene.

Authors:  F Rozen; C Russo; D Banville; H H Zingg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-03       Impact factor: 11.205

9.  Characterization of cloned human somatostatin receptor SSTR5.

Authors:  A M O'Carroll; K Raynor; S J Lolait; T Reisine
Journal:  Mol Pharmacol       Date:  1994-08       Impact factor: 4.436

10.  Identification and characterization of a vasopressin isoreceptor in porcine seminal vesicles.

Authors:  M Maggi; S Kassis; S Malozowski; V Guardabasso; D Rodbard
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

View more
  49 in total

1.  Design, synthesis, and pharmacological characterization of fluorescent peptides for imaging human V1b vasopressin or oxytocin receptors.

Authors:  Maithé Corbani; Miguel Trueba; Stoytcho Stoev; Brigitte Murat; Julie Mion; Véra Boulay; Gilles Guillon; Maurice Manning
Journal:  J Med Chem       Date:  2011-03-23       Impact factor: 7.446

Review 2.  Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?

Authors:  Guy Griebel; Florian Holsboer
Journal:  Nat Rev Drug Discov       Date:  2012-05-18       Impact factor: 84.694

3.  Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V1b/oxytocin receptor antagonist.

Authors:  Cristiana Griffante; Andrew Green; Ornella Curcuruto; Carl P Haslam; Bryony A Dickinson; Roberto Arban
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

4.  Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V1B receptor antagonists: TASP0233278 and TASP0390325.

Authors:  M Iijima; T Yoshimizu; T Shimazaki; K Tokugawa; K Fukumoto; S Kurosu; T Kuwada; Y Sekiguchi; S Chaki
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

5.  Social dominance in male vasopressin 1b receptor knockout mice.

Authors:  Heather K Caldwell; Obianuju E Dike; Erica L Stevenson; Kathryn Storck; W Scott Young
Journal:  Horm Behav       Date:  2010-03-16       Impact factor: 3.587

6.  Involvement of arginine vasopressin and V1b receptor in alcohol drinking in Sardinian alcohol-preferring rats.

Authors:  Yan Zhou; Giancarlo Colombo; Mauro A M Carai; Ann Ho; Gian Luigi Gessa; Mary Jeanne Kreek
Journal:  Alcohol Clin Exp Res       Date:  2011-05-16       Impact factor: 3.455

7.  Bacterial lipopolysaccharide-induced coordinate downregulation of arginine vasopressin receptor V3 and corticotropin-releasing factor receptor 1 messenger ribonucleic acids in the anterior pituitary of endotoxemic steers.

Authors:  Isam M Qahwash; Carolyn A Cassar; Roy P Radcliff; George W Smith
Journal:  Endocrine       Date:  2002-06       Impact factor: 3.633

Review 8.  Role of various neurotransmitters in mediating the long-term endocrine consequences of prenatal alcohol exposure.

Authors:  Soon Lee; Irene Choi; Sang Kang; Catherine Rivier
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

9.  Role of vasopressin V1a receptor in ∆9-tetrahydrocannabinol-induced cataleptic immobilization in mice.

Authors:  Nobuaki Egashira; Emi Koushi; Takayuki Myose; Akito Tanoue; Kenichi Mishima; Ryota Tsuchihashi; Junei Kinjo; Hiroyuki Tanaka; Satoshi Morimoto; Katsunori Iwasaki
Journal:  Psychopharmacology (Berl)       Date:  2017-09-14       Impact factor: 4.530

Review 10.  Trends in the development of new antidepressants. Is there a light at the end of the tunnel?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Med Chem       Date:  2004-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.